Human medicines: highlights of 2023

EMA

16 January 2024 - In 2023, EMA recommended 77 medicines for marketing authorisation. 

Of these, 39 had a new active substance which had never been authorised in the European Union before. Among these are a number of medicines that stand out due to their contribution to address public health needs or the innovation they represent.

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Europe , Regulation , Review